Rodriguez-Garcia E, Zabaleta N, Gil-Farina I, Gonzalez-Aparicio M, et al. AdrA as a Potential Immunomodulatory Candidate for STING-Mediated Antiviral Therapy That Required Both Type I IFN and TNF-alpha Production. J Immunol 2021;206:376-385.
PMID: 33298616